Skip to content

Gerardo Turcatti

Gerardo Turcatti


About Gerardo Turcatti

Gerardo Turcatti, M.E.R., directs the Biomolecular Screening Facility, a multidisciplinary laboratory created in 2006 at the EPFL, to perform medium and high throughput screening in life sciences-related projects at the EPF. The facility has the necessary infrastructure, multidisciplinary expertise and flexibility to perform large screening programs using small interfering RNAs (siRNAs) and chemical collections in the areas of chemical biology, systems biology and drug discovery.  Within the frame of the NCCR Chemical Biology, BSF developed the Academic Chemical Screening platform of Switzerland (ACCESS), so as to providethe scientific community with chemical diversity, screening facilities and know-how in chemical genetics. In addition, the BSF started its own applied research axes that are driven by innovation in thematic areas related to preclinical drug discovery and discovery of bioactive probes.

Read more about Gerardo Turcatti’s research on his lab website.


AAB 003 (Bâtiment AAB)
Station 15
1015 Lausanne, Switzerland
Phone : +41(0)21 693 96 66


Kale S.S., Bergeron-Brlek M., Wu Y., Kumar M.G., Pham M.V., Bortoli J., Vesin J., Kong X.D., Machado J.F., Deyle K., Gonschorek P., Turcatti G., Cendron L., Angelini A., Heinis C., “Thiol-to-amine cyclization reaction enables screening of large libraries of macrocyclic compounds and the generation of sub-kilodalton ligands”, Science Advances, 5, eaaw2851. Open access [More Information]

Scott C.C., Vossio S., Vacca F., Snijder B., Larios J., Schaad O., Guex N., Kuznetsov D., Martin O., Chambon M., Turcatti G., Pelkmans L., and Gruenberg J. “Wnt directs the endosomal flux of LDL-derived cholesterol and lipid droplet homeostasis”. EMBO reports. DOI 10.15252/embr.201540081, (2015). [More Information]